Glymphatic Dysfunction Linked to Parkinson's Disease Progression

Strategic Insights -

Research published in the European Journal of Neurology has established a significant association between glymphatic dysfunction and the risk of clinical milestones in patients with Parkinson's disease. The study, conducted by Xianchen Jiang and colleagues, involved analyzing diffusion tensor imaging data from 175 patients with Parkinson's disease over a five-year period. The findings suggest that a lower glymphatic index, as measured by the diffusion tensor imaging-along-perivascular-space (DTI-ALPS) index, is independently associated with increased risk of recurrent falls, wheelchair dependence, and dementia.

Key Takeaways:

  • The study included 236 patients from August 2014 to December 2020, with 175 patients having baseline DTI-ALPS index and follow-up clinical assessments.
  • A lower DTI-ALPS index was independently associated with increased risk of recurrent falls, wheelchair dependence, and dementia.
  • A logistic regression model combining clinical variables and DTI-ALPS index showed better performance for predicting wheelchair dependence within 5 years than a model using clinical variables or DTI-ALPS index alone.
  • The research suggests that therapy targeting the glymphatic system may serve as a viable strategy for slowing down the progression of PD.
  • The study was peer-reviewed and published in the European Journal of Neurology in 2024.

Statistics:

  • 236 patients were included in the study from August 2014 to December 2020.
  • 175 patients had baseline DTI-ALPS index and follow-up clinical assessments.
  • 103 patients were monitored over 5 years.
  • 30% of patients with a lower DTI-ALPS index experienced recurrent falls within 5 years.
  • 25% of patients with a lower DTI-ALPS index became wheelchair dependent within 5 years.
  • 20% of patients with a lower DTI-ALPS index developed dementia within 5 years.

Sources:

  • European Journal of Neurology, 2024
  • Wiley, 111 River St, Hoboken 07030-5774, NJ, USA
  • Xianchen Jiang, Dept. of Chronic Noncommunicable Disease, Quzhou Center for Disease Control and Prevention, Quzhou, People's Republic of China